Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2010 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EXACT SCIENCES CORP | 22 | Q1 2024 | 1.1% |
SAREPTA THERAPEUTICS INC | 21 | Q2 2024 | 1.5% |
AURINIA PHARMACEUTICALS INC | 21 | Q2 2024 | 0.4% |
AMICUS THERAPEUTICS INC | 21 | Q2 2024 | 0.2% |
SUNRUN INC | 20 | Q2 2024 | 2.4% |
UNIQURE NV | 20 | Q2 2024 | 2.4% |
PG&E CORP | 20 | Q2 2023 | 0.8% |
KOHLS CORP | 20 | Q2 2024 | 1.6% |
BIOMARIN PHARMACEUTICAL INC | 20 | Q2 2024 | 1.0% |
BIOMARIN PHARMACEUTICAL INC | 20 | Q2 2024 | 1.0% |
View Caption Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
SC 13G | 2022-09-02 |
View Caption Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.